HOUSTON, TX / ACCESS Newswire / September 11, 2025 / EON Resources Inc. (NYSE American:EONR) (“EON” or the “Company”) is an ...

For too long, the working communities on which previous generations of economic success were founded have been abandoned” – Marie Macklin ...

Under the agreement, Jamjoom Pharma will obtain the exclusive rights to commercialize BAT2306 - a proposed biosimilar to Novartis’ Cosentyx® (secukinumab) across MENA ...

A company that develops property nationwide has spent $23 million to acquire land in greater Hazleton where it already has built a 1-million-square foot warehouse and plans the region’s ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing ...

Unlike GPT-5, which is built as a general-purpose AI model, GPT-5-Codex is optimized for what OpenAI calls “agentic coding," ...

GPT-5-Codex now extends this unified setup with deeper engineering capabilities — even running "independently for more than 7 ...

HOUSTON, TX / ACCESS Newswire / September 10, 2025 / EON Resources Inc. (NYSE American:EONR) (“EON” or the “Company”) is an independent upstream energy company with 20,000 leasehold acres in the ...

On Tuesday, City Council will hear from the city’s economic development team and airport management about a new business ...

Thomas Kurian talks Google Cloud AI momentum with Gemini, $106 billion backlog, data platform BigQuery customers, and AI agents at Goldman Sachs event.

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that data from the Phase 2b ANTHEM-UC study with icotrokinra in ulcerative colitis will be the focus of a brief oral ...

The automaker's new world headquarters will be located about a mile west of its current HQ, which served the company since 1956.